{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:46:27Z","timestamp":1792583187608,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.modpat.2026.101053","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:17:05Z","timestamp":1785885425000},"page":"101053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Concepts in Pituitary Pathology"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2026.101053_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000079035","article-title":"Molecular basis of pituitary development and cytogenesis","volume":"32","author":"Asa","year":"2004","journal-title":"Front Horm Res"},{"issue":"6","key":"10.1016\/j.modpat.2026.101053_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101371","article-title":"Hypophysitis: an update on the novel forms, diagnosis and management of disorders of pituitary inflammation","volume":"33","author":"Gubbi","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.modpat.2026.101053_bib3","series-title":"Tumors of the Pituitary Gland","author":"Asa","year":"2020"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1750-3639.2012.00599.x","article-title":"Clinicopathological correlations in pituitary adenomas","volume":"22","author":"Mete","year":"2012","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12022-020-09646-x","article-title":"Structure, function, and morphology in the classification of pituitary neuroendocrine tumors: the importance of routine analysis of pituitary transcription factors","volume":"31","author":"Mete","year":"2020","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101053_bib6","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41379-021-00820-y","article-title":"Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification","volume":"34","author":"Asa","year":"2021","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101053_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jcem.86.3.7265","article-title":"The spectrum and significance of primary hypophysitis","volume":"86","author":"Cheung","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.modpat.2026.101053_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.7326\/0003-4819-95-2-166","article-title":"Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity","volume":"95","author":"Asa","year":"1981","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.modpat.2026.101053_bib9","first-page":"2302","article-title":"Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings","volume":"80","author":"Thodou","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.modpat.2026.101053_bib10","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","volume":"96","author":"Leporati","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.modpat.2026.101053_bib11","article-title":"Histologically confirmed isolated IgG4-related hypophysitis: two case reports in young women","volume":"2014","author":"Sosa","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12022-023-09771-3","article-title":"Inflammatory and infectious disorders in endocrine pathology","volume":"34","author":"Uccella","year":"2023","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12022-017-9471-x","article-title":"Xanthomatous hypophysitis is associated with ruptured Rathke\u2019s cleft cyst","volume":"28","author":"Duan","year":"2017","journal-title":"Endocr Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101053_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-0033-1355337","article-title":"Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy","volume":"121","author":"Lammert","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12032-010-9794-7","article-title":"Hyponatremia associated with ipilimumab-induced hypophysitis","volume":"29","author":"Barnard","year":"2012","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101053_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/17446651.2019.1701434","article-title":"Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment","volume":"14","author":"Di Dalmazi","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib17","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101053_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12022-019-9568-5","article-title":"An institutional experience of tumor progression to pituitary carcinoma in a 15-year cohort of 1055 consecutive pituitary neuroendocrine tumors","volume":"30","author":"Alshaikh","year":"2019","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/clinem\/dgaa749","article-title":"Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations","volume":"106","author":"Casar-Borota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.modpat.2026.101053_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/17446651.2016.1153422","article-title":"Aggressive pituitary tumors or localized pituitary carcinomas: defining pituitary tumors","volume":"11","author":"Asa","year":"2016","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101053_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12022-021-09671-4","article-title":"The pangenomic classification of pituitary neuroendocrine tumors: quality histopathology is required for accurate translational research","volume":"32","author":"Mete","year":"2021","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib23","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1530\/EO-22-0041","article-title":"Pituitary carcinoma: reclassification and implications in the NET schema","volume":"2","author":"Asa","year":"2022","journal-title":"Endocr Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101053_bib24","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib26","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12022-024-09829-w","article-title":"High-grade progression, sarcomatous transformation, and\/or metastasis of pituitary neuroendocrine neoplasms (PitNENs): the UCSF experience","volume":"35","author":"Terry","year":"2024","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12022-024-09835-y","article-title":"Progression of low-grade neuroendocrine tumors (NET) to high-grade neoplasms harboring the NEC-like co-alteration of RB1 and TP53","volume":"35","author":"Joseph","year":"2024","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101053_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12022-018-9521-z","article-title":"Immunohistochemical biomarkers in pituitary pathology","volume":"29","author":"Asa","year":"2018","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12022-018-9545-4","article-title":"Synchronous multiple pituitary neuroendocrine tumors of different cell lineages","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-024-09841-0","article-title":"Multilineage pituitary neuroendocrine tumors expressing TPIT and SF1: a clinicopathological series of six tumors","volume":"35","author":"Asa","year":"2024","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101053_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12022-023-09777-x","article-title":"Multilineage pituitary neuroendocrine tumors (PitNETs) expressing PIT1 and SF1","volume":"34","author":"Asa","year":"2023","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.modpat.2026.101053_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.humpath.2020.10.004","article-title":"Cytokeratin profiles in pituitary neuroendocrine tumors","volume":"107","author":"Asa","year":"2021","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101053_bib33","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2006-0610","article-title":"Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma","volume":"91","author":"Nasr","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib34","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12022-013-9279-2","article-title":"TTF-1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma","volume":"25","author":"Kamil","year":"2014","journal-title":"Endocr Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101053_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/PAS.0000000000001185","article-title":"Hypothalamic vasopressin-producing tumors: often inappropriate diuresis but occasionally Cushing disease","volume":"43","author":"Asa","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101053_bib36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/nan.12201","article-title":"BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke\u2019s cleft cysts","volume":"41","author":"Schweizer","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101053_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","article-title":"Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region","volume":"109","author":"Buslei","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.modpat.2026.101053_bib52","doi-asserted-by":"crossref","DOI":"10.5858\/arpa.2025-0644-OA","article-title":"Cross-reactivity of TPIT antibody clone OTI2G1 in chordoma: structural mechanisms and diagnostic implications","author":"Hong","year":"2026","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12022-023-09768-y","article-title":"The driver role of pathologists in endocrine oncology: what clinicians seek in pathology reports","volume":"34","author":"Ezzat","year":"2023","journal-title":"Endocr Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101053_bib40","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/jcm10112254","article-title":"An update on pituitary neuroendocrine tumors leading to acromegaly and gigantism","volume":"10","author":"Asa","year":"2021","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.modpat.2026.101053_bib41","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3390\/jcm8111962","article-title":"The clinicopathological spectrum of acromegaly","volume":"8","author":"Akirov","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.modpat.2026.101053_bib42","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/ERC-16-0496","article-title":"Pituitary acromegaly: not one disease","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4158\/EP-2018-0500","article-title":"Predictive markers fo postsurgical medical management of acromegaly: a systematic review and consensus treatment guideline","volume":"25","author":"Ezzat","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.modpat.2026.101053_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.620005","article-title":"Significance of Crooke\u2019s hyaline change in nontumorous corticotrophs of patients with Cushing disease","volume":"12","author":"Akirov","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.modpat.2026.101053_bib45","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101053_bib46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/jpi.jpi_76_18","article-title":"Ki67 quantitative interpretation: insights using image analysis","volume":"10","author":"Volynskaya","year":"2019","journal-title":"J Pathol Inform"},{"key":"10.1016\/j.modpat.2026.101053_bib47","author":"Mete"},{"issue":"1","key":"10.1016\/j.modpat.2026.101053_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12022-021-09701-1","article-title":"From counting mitoses to Ki67 assessment: technical pitfalls in the new WHO Classification of Endocrine and Neuroendocrine Tumors","volume":"33","author":"Cree","year":"2022","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101053_bib49","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41379-021-00825-7","article-title":"Counting mitoses: SI(ze) matters","volume":"34","author":"Cree","year":"2021","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101053_bib50","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/PAS.0000000000000784","article-title":"Pituitary adenomas presenting as sinonasal or nasopharyngeal masses: a case series illustrating potential diagnostic pitfalls","volume":"41","author":"Hyrcza","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101053_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12022-020-09639-w","article-title":"Mixed sparsely granulated lactotroph and densely granulated somatotroph pituitary neuroendocrine tumor expands the spectrum of neuroendocrine neoplasms in ovarian teratomas: the role of pituitary neuroendocrine cell lineage biomarkers","volume":"31","author":"Hodgson","year":"2020","journal-title":"Endocr Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:28:52Z","timestamp":1792582132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0893395226000967"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101053","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Concepts in Pituitary Pathology","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101053"}}